The U.S. accounts for 42-45% of global pharmaceutical sales, not 74% – but the core truth remains: Americans pay 3x more for drugs than other nations. While we develop 43.7% of new medicines, Big Pharma's price-gouging turns life-saving treatments into luxury goods.